Global 23-Valent Pneumococcal Polysaccharide Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1140 million in 2023 and is forecast to a readjusted size of USD 2212 million by 2030 with a CAGR of 10.0% during review period.
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Market Drivers:
The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is driven by the increasing prevalence of pneumococcal infections, particularly among high-risk populations such as the elderly, children, and immunocompromised individuals. Governments and health organizations worldwide are promoting vaccination programs to reduce the burden of pneumococcal diseases, which has significantly boosted market growth. Additionally, rising awareness about the importance of preventive healthcare and advancements in vaccine manufacturing technologies contribute to the increased adoption of PPSV23 vaccines.
Market Challenges:
However, the market faces challenges such as the high cost of vaccination, which limits accessibility in low- and middle-income countries. Moreover, the competition from newer pneumococcal conjugate vaccines (PCVs), which offer broader coverage and are preferred for pediatric use, poses a threat to PPSV23's market share. Another concern is vaccine hesitancy and misinformation, which can hinder immunization efforts and impact the overall market growth.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
This report is a detailed and comprehensive analysis for global 23-Valent Pneumococcal Polysaccharide Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global 23-Valent Pneumococcal Polysaccharide Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global 23-Valent Pneumococcal Polysaccharide Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global 23-Valent Pneumococcal Polysaccharide Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global 23-Valent Pneumococcal Polysaccharide Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 23-Valent Pneumococcal Polysaccharide Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global 23-Valent Pneumococcal Polysaccharide Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sinovac, Kangtai Bio, CDIBP, Walvax, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
23-Valent Pneumococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single Dose Vial
- Pre-filled Syringe
Market segment by Application
- For Children (Over 2 Years Old)
- For Adult
Major players covered
- Merck
- Sinovac
- Kangtai Bio
- CDIBP
- Walvax
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 23-Valent Pneumococcal Polysaccharide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, with price, sales quantity, revenue, and global market share of 23-Valent Pneumococcal Polysaccharide Vaccine from 2019 to 2024.
Chapter 3, the 23-Valent Pneumococcal Polysaccharide Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 23-Valent Pneumococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and 23-Valent Pneumococcal Polysaccharide Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of 23-Valent Pneumococcal Polysaccharide Vaccine.
Chapter 14 and 15, to describe 23-Valent Pneumococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion.
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
Market Drivers:
The 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) market is driven by the increasing prevalence of pneumococcal infections, particularly among high-risk populations such as the elderly, children, and immunocompromised individuals. Governments and health organizations worldwide are promoting vaccination programs to reduce the burden of pneumococcal diseases, which has significantly boosted market growth. Additionally, rising awareness about the importance of preventive healthcare and advancements in vaccine manufacturing technologies contribute to the increased adoption of PPSV23 vaccines.
Market Challenges:
However, the market faces challenges such as the high cost of vaccination, which limits accessibility in low- and middle-income countries. Moreover, the competition from newer pneumococcal conjugate vaccines (PCVs), which offer broader coverage and are preferred for pediatric use, poses a threat to PPSV23's market share. Another concern is vaccine hesitancy and misinformation, which can hinder immunization efforts and impact the overall market growth.
Merck is the largest manufacturers of 23-Valent pneumococcal polysaccharide vaccine in the world, has a share about 78%. Other players include Sinovac, Kangtai Bio, CDIBP, Walvax, etc. United States is dominating the global 23-Valent pneumococcal polysaccharide vaccine market, has a share nearly 78% in terms of production. The largest market is United States, holds a share about 48%, followed by China and Europe, with around 25% and 22% market share respectively.
This report is a detailed and comprehensive analysis for global 23-Valent Pneumococcal Polysaccharide Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global 23-Valent Pneumococcal Polysaccharide Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global 23-Valent Pneumococcal Polysaccharide Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global 23-Valent Pneumococcal Polysaccharide Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2019-2030
Global 23-Valent Pneumococcal Polysaccharide Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for 23-Valent Pneumococcal Polysaccharide Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global 23-Valent Pneumococcal Polysaccharide Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Sinovac, Kangtai Bio, CDIBP, Walvax, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
23-Valent Pneumococcal Polysaccharide Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Single Dose Vial
- Pre-filled Syringe
Market segment by Application
- For Children (Over 2 Years Old)
- For Adult
Major players covered
- Merck
- Sinovac
- Kangtai Bio
- CDIBP
- Walvax
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe 23-Valent Pneumococcal Polysaccharide Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine, with price, sales quantity, revenue, and global market share of 23-Valent Pneumococcal Polysaccharide Vaccine from 2019 to 2024.
Chapter 3, the 23-Valent Pneumococcal Polysaccharide Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the 23-Valent Pneumococcal Polysaccharide Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and 23-Valent Pneumococcal Polysaccharide Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of 23-Valent Pneumococcal Polysaccharide Vaccine.
Chapter 14 and 15, to describe 23-Valent Pneumococcal Polysaccharide Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Single Dose Vial
1.3.3 Pre-filled Syringe
1.4 Market Analysis by Application
1.4.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 For Children (Over 2 Years Old)
1.4.3 For Adult
1.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size & Forecast
1.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (2019-2030)
1.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.1.4 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sinovac
2.2.1 Sinovac Details
2.2.2 Sinovac Major Business
2.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.2.4 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sinovac Recent Developments/Updates
2.3 Kangtai Bio
2.3.1 Kangtai Bio Details
2.3.2 Kangtai Bio Major Business
2.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.3.4 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Kangtai Bio Recent Developments/Updates
2.4 CDIBP
2.4.1 CDIBP Details
2.4.2 CDIBP Major Business
2.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.4.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 CDIBP Recent Developments/Updates
2.5 Walvax
2.5.1 Walvax Details
2.5.2 Walvax Major Business
2.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.5.4 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Walvax Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY MANUFACTURER
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
3.4.3 Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
3.5 23-Valent Pneumococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market: Region Footprint
3.5.2 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.5.3 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Region (2019-2030)
4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.5 South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type (2019-2030)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application (2019-2030)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
7.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
7.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
7.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
9.3.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
10.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
10.3 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
10.3.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
11.3.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of 23-Valent Pneumococcal Polysaccharide Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of 23-Valent Pneumococcal Polysaccharide Vaccine
13.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 23-Valent Pneumococcal Polysaccharide Vaccine Typical Distributors
14.3 23-Valent Pneumococcal Polysaccharide Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Single Dose Vial
1.3.3 Pre-filled Syringe
1.4 Market Analysis by Application
1.4.1 Overview: Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 For Children (Over 2 Years Old)
1.4.3 For Adult
1.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size & Forecast
1.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (2019-2030)
1.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.1.4 Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck Recent Developments/Updates
2.2 Sinovac
2.2.1 Sinovac Details
2.2.2 Sinovac Major Business
2.2.3 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.2.4 Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sinovac Recent Developments/Updates
2.3 Kangtai Bio
2.3.1 Kangtai Bio Details
2.3.2 Kangtai Bio Major Business
2.3.3 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.3.4 Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Kangtai Bio Recent Developments/Updates
2.4 CDIBP
2.4.1 CDIBP Details
2.4.2 CDIBP Major Business
2.4.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.4.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 CDIBP Recent Developments/Updates
2.5 Walvax
2.5.1 Walvax Details
2.5.2 Walvax Major Business
2.5.3 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.5.4 Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Walvax Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE BY MANUFACTURER
3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
3.4.3 Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2023
3.5 23-Valent Pneumococcal Polysaccharide Vaccine Market: Overall Company Footprint Analysis
3.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market: Region Footprint
3.5.2 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Type Footprint
3.5.3 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Region (2019-2030)
4.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.5 South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
4.6 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type (2019-2030)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application (2019-2030)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
7.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
7.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
7.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.3.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
9.3.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
10.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
10.3 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
10.3.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
11.3.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
12.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
12.3 23-Valent Pneumococcal Polysaccharide Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of 23-Valent Pneumococcal Polysaccharide Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of 23-Valent Pneumococcal Polysaccharide Vaccine
13.3 23-Valent Pneumococcal Polysaccharide Vaccine Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 23-Valent Pneumococcal Polysaccharide Vaccine Typical Distributors
14.3 23-Valent Pneumococcal Polysaccharide Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 6. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sinovac Basic Information, Manufacturing Base and Competitors
Table 9. Sinovac Major Business
Table 10. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 11. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sinovac Recent Developments/Updates
Table 13. Kangtai Bio Basic Information, Manufacturing Base and Competitors
Table 14. Kangtai Bio Major Business
Table 15. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 16. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Kangtai Bio Recent Developments/Updates
Table 18. CDIBP Basic Information, Manufacturing Base and Competitors
Table 19. CDIBP Major Business
Table 20. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 21. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. CDIBP Recent Developments/Updates
Table 23. Walvax Basic Information, Manufacturing Base and Competitors
Table 24. Walvax Major Business
Table 25. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 26. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Walvax Recent Developments/Updates
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 31. Market Position of Manufacturers in 23-Valent Pneumococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 32. Head Office and 23-Valent Pneumococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 33. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 34. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 35. 23-Valent Pneumococcal Polysaccharide Vaccine New Market Entrants and Barriers to Market Entry
Table 36. 23-Valent Pneumococcal Polysaccharide Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 45. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 46. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 47. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 48. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 49. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 56. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 57. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 58. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 59. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 60. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 61. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 62. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 63. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 66. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 67. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 68. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 69. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 70. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 71. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 73. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 74. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 77. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 78. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 80. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 81. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 82. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 83. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 84. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 85. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 86. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 96. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 97. Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 98. 23-Valent Pneumococcal Polysaccharide Vaccine Typical Distributors
Table 99. 23-Valent Pneumococcal Polysaccharide Vaccine Typical Customers
Table 1. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 6. Merck 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck Recent Developments/Updates
Table 8. Sinovac Basic Information, Manufacturing Base and Competitors
Table 9. Sinovac Major Business
Table 10. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 11. Sinovac 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sinovac Recent Developments/Updates
Table 13. Kangtai Bio Basic Information, Manufacturing Base and Competitors
Table 14. Kangtai Bio Major Business
Table 15. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 16. Kangtai Bio 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Kangtai Bio Recent Developments/Updates
Table 18. CDIBP Basic Information, Manufacturing Base and Competitors
Table 19. CDIBP Major Business
Table 20. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 21. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. CDIBP Recent Developments/Updates
Table 23. Walvax Basic Information, Manufacturing Base and Competitors
Table 24. Walvax Major Business
Table 25. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 26. Walvax 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Walvax Recent Developments/Updates
Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 31. Market Position of Manufacturers in 23-Valent Pneumococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 32. Head Office and 23-Valent Pneumococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 33. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Type Footprint
Table 34. 23-Valent Pneumococcal Polysaccharide Vaccine Market: Company Product Application Footprint
Table 35. 23-Valent Pneumococcal Polysaccharide Vaccine New Market Entrants and Barriers to Market Entry
Table 36. 23-Valent Pneumococcal Polysaccharide Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 37. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Region (2019-2024) & (USD/Unit)
Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Region (2025-2030) & (USD/Unit)
Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 45. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 46. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 47. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 48. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2019-2024) & (USD/Unit)
Table 49. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2025-2030) & (USD/Unit)
Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2019-2024) & (USD/Unit)
Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2025-2030) & (USD/Unit)
Table 56. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 57. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 58. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 59. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 60. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 61. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 62. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 63. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 65. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 66. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 67. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 68. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 69. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 70. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 71. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 73. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 74. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2019-2024) & (K Units)
Table 77. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Region (2025-2030) & (K Units)
Table 78. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 80. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 81. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 82. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 83. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 84. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 85. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 86. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 87. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2019-2024) & (K Units)
Table 89. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Type (2025-2030) & (K Units)
Table 90. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2019-2024) & (K Units)
Table 91. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Application (2025-2030) & (K Units)
Table 92. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2019-2024) & (K Units)
Table 93. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity by Country (2025-2030) & (K Units)
Table 94. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 96. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 97. Key Manufacturers of 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 98. 23-Valent Pneumococcal Polysaccharide Vaccine Typical Distributors
Table 99. 23-Valent Pneumococcal Polysaccharide Vaccine Typical Customers
LIST OF FIGURES
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Picture
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type in 2023
Figure 4. Single Dose Vial Examples
Figure 5. Pre-filled Syringe Examples
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 8. For Children (Over 2 Years Old) Examples
Figure 9. For Adult Examples
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (2019-2030) & (USD/Unit)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2023
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
Figure 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 44. France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 55. India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 58. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 72. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Figure 73. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Figure 74. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2023
Figure 77. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 78. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Picture
Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type in 2023
Figure 4. Single Dose Vial Examples
Figure 5. Pre-filled Syringe Examples
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2023
Figure 8. For Children (Over 2 Years Old) Examples
Figure 9. For Adult Examples
Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity (2019-2030) & (K Units)
Figure 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (2019-2030) & (USD/Unit)
Figure 14. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of 23-Valent Pneumococcal Polysaccharide Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 17. Top 3 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2023
Figure 18. Top 6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2023
Figure 19. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2019-2030)
Figure 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 37. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 38. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 39. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 44. France 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 55. India 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 58. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 63. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 64. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 67. Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 68. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 69. Egypt 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 70. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 71. South Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 72. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Figure 73. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Figure 74. 23-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine in 2023
Figure 77. Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 78. 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain
Figure 79. Sales Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
